BCF Life Sciences
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
BCF Life Sciences - overview
Established
1986
Location
-, -, France
Primary Industry
Chemicals
About
Based in Pleucadeuc, France, and founded in 1986, BCF Life Sciences, formerly known as Bretagne Chimie Fine SAS, operates as a producer of amino acids that include L-Cystine, L-Tyrosine, Cysteine, Kéramine, and Carbocisteine used in pharmaceutical, healthcare, and food applications. In April 2024, Sparkfood acquired BCF Life Sciences from MBO+. As of 2024, the company is led by its CEO, Jacques Pidoux. The company provides a wide range of amino acid-based products, such as dietary supplements, hypoallergenic infant nutrition, and pharmaceutical ingredients like carbocistein.
Additionally, BCF Life Sciences offers functional amino acids for aquaculture and plant biostimulants for sustainable agriculture.
Current Investors
MBO+
Primary Industry
Chemicals
Sub Industries
Biopharmaceuticals, Agricultural Chemicals
Website
www.bcf-lifesciences.com/
Verticals
Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only
BCF Life Sciences - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Secondary Buyout | Completed | BCF Life Sciences | - | ||||||||
| Secondary Buyout | Completed | BCF Life Sciences | - | ||||||||
| Secondary Buyout | Completed | BCF Life Sciences | - | ||||||||
| Buyout | Completed | BCF Life Sciences | - |
Displaying 1 - 4 of 4
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.